Unexpected replication pathways of foamy viruses

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Rethwilm, Axel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

DNA viruses; Foamy viruses; Pararetroviruses; Retroviruses; RNa viruses

Indexed keywords

CONFERENCE PAPER; DNA VIRUS; GENE TRANSFER; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RNA VIRUS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSMISSION; ZOONOSIS;

ANIMALIA; DNA VIRUSES; HEPATITIS B VIRUS; HUMAN SPUMARETROVIRUS; PRIMATES; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0029757712     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00037     Document Type: Conference Paper

References (52)

1. Teich N. Taxonomy of retroviruses. In: Weiss RA, Teich N, Varmus HE, Coffin J, eds. RNA tumor viruses. New York: Cold Spring Harbor Laboratory Press, 1984:25-208.
2. Hooks JJ, Gibbs CJ. The foamy viruses. Bacteriol Rev 1975; 39:169-85.
3. Hooks JJ, Detrick-Hooks B. Spumavirinae: foamy virus group infections: comparative aspects and diagnosis. In: Kurstak E, Kurstak C, eds. Comparative diagnosis of viral diseases, Vol. IV. New York: Academic Press, 1981:599-618.
4. Schweizer M, Turek R, Reinhardt M, Neumann-Haefelin D. Absence of foamy virus DNA in Grave's disease. AIDS Res Hum Retroviruses 1994;10:601-5.
5. Schweizer M, Turek R, Hahn H, et al. Markers or foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995;11:161-70.
6. Rethwilm A. Regulation of foamy virus gene expression. Curr Topics Microbiol Immunol 1995;193:1-24.
7. Achong BG, Mansell PWA, Epstein MA, Clifford P. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971;46:299-307.
8. Herchenröder O, Renne R, Loncar D, et al. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 1994;201:187-99.
9. Bothe K, Aguzzi A, Lassmann H, Rethwilm A, Horak I. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science 1991; 253:555-7.
10. Tschopp RR, Brandner S, Marino S, et al. Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice. Virology 1996;216:338-46.
11. Aguzzi A, Marino S, Tschopp S, Rethwilm A. Regulation of expression and pathogenic potential of human foamy virus in vitro and in transgenic mice. Curr Topics Microbiol Immunol 1996;206:243-73.
12. Hahn H, Baunach G, Bräutigam S, et al. Reactivity of primate sera to foamy virus gag and bet proteins. J Gen Virol 1994;75:2635-44.
13. Rösener M, Kranz M, Hahn H, Heeney J, Rethwilm A. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 1996 (in press).
14. Ali M, Taylor G, Pitman R, et al. No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Relrovirus (in press).
15. Rethwilm A, Erlwein O, Baunach G, Maurer B, ter Meulen V. The transcriptional transactivator of human foamy virus maps to the bell genomic region. Proc Natl Acad Sci USA 1991;88:941-5.
16. Keller A, Partin KM, Löchelt M, Bannert H, Flügel RM, Cullen BR. Characterization of the transcriptional trans activator of human foamy virus. J Virol 1991;65:2589-94.
17. Venkatesh LK, Yang C, Theodorakis PA, Chinnadurai G. Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. J Virol 1993;67:161-9.
18. Baunach G, Maurer B, Hahn H, Kranz M, Rethwilm A. Functional analysis of human foamy virus accessory reading frames. J Virol 1993;67:5411-8.
19. Yu SF, Linial ML. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol 1993;67:6618-24.
20. Erlwein O, Rethwilm A. Bel-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology 1993;196:256-68.
21. Lee KJ, Lee AH, Sung YC. Multiple positive and negative cis-acting elements that mediate transactivation by bell in the long terminal repeat of human foamy virus. J Virol 1993; 67:2317-26.
22. Löchelt M, Muranyi W, Flügel RM. Human foamy virus genome possesses an internal, bell-dependent and functional promoter. Proc Natl Acad Sci USA 1993;90:7317-21.
23. Löchelt M, Yu S, Linial M, Flügel RM. The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology 1995;206:601-10.
24. Campbell M, Renshaw-Gegg L, Renne R, Luciw PA. Characterization of the internal promoter of simian foamy viruses. J Virol 1994;68:4811-20.
25. Löchelt M, Flügel RM, Aboud M. The human foamy virus internal promoter directs expression of the functional bell transactivator and bet protein early after infection. J Virol 1994;68:638-45.
26. Cullen BR. Human immunodeficiency virus as a prototypic complex retrovirus. J Virol 1991;65:1053-6.
27. Zou JX, Luciw PA. The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proc Natl Acad Sci USA 1996;93: 326-30.
28. Muranyi W, Flügel RM. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol 1991;65:727-35.
29. Saib A, Périès J, de Thé H. A defective human foamy provirus generated by pregenome splicing. EMBO J 1993;12: 4439-44.
30. Saib A, Kooken MHM, van der Spek P, Périès J, de Thé H. Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol 1995;69: 5261-8.
31. Jacks T. Translational suppression in gene expression in retroviruses and retrotransposons. Curr Topics Microbiol Immunol 1990;157:93-124.
32. Levin JG, Hatfield DL, Oroszlan S, Rein A. Mechanisms of translational suppression used in the biosynthesis of reverse transcriptase. In: Skalka AM, Goff SP, eds. Reverse transcriptase. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993:5-31.
33. Loeb DD, Ganem D. Reverse transcription pathway of the hepatitis B virus. In: Skalka AM, Goff SP, eds. Reverse transcriptase. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993:329-55.
34. Bonneville J-M, Hohn T. A reverse transcriptase for cauliflower mosaic virus - state of the art, 1992. In: Skalka AM, Goff SP, eds. Reverse transcriptase. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1993:357-90.
35. Netzer K-O, Schliephake A, Maurer B, Watanabe R, Aguzzi A, Rethwilm A. Identification of pol-related gene products of human foamy virus. Virology 1993;192:336-8.
36. Löchelt M, Flügel RM. Human foamy virus pol gene is expressed as a pro-pol polyprotein and not as a gag-pol fusion protein. J Virol 1996;70:1033-40.
37. Enssle J, Jordan I, Mauer B, Rethwilm A. Foamy virus reverse transcriptase is expressed independently from the gag protein. Proc Natl Acad Sci USA 1996;93:4137-41.
38. Yu S, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 1996;271:1579-82.
39. Jordan I, Enssle J, Güttler E, Mauer B, Rethwilm A. Expression of foamy virus reverse transcriptase involves a spliced pol transcript originating in the LTR and a cryptic promoter in the gag gene. Virology 1996 (in press).
40. Nassal M, Schaller H. Hepatitis B virus replication. Trends Microbiol 1993;1:221-8.
41. Linial ML, Miller AD. Retroviral RNA packaging: sequence requirements and implications. Curr Topics Microbiol Immunol 1990;157:125-52.
42. Schliephake AW, Rethwilm A. Nuclear localization of foamy virus gag precursor protein. J Virol 1994;68:4946-54.
43. Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986;47:451-60.
44. Mergia A, Luciw PA. Replication and regulation of primate foamy viruses. Virology 1991;184:475-82.
45. Summers J, Smith PM, Horwich AL. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 1990;64:2819-24.
46. Goepfert PA, Wang G, Mulligan MJ. Identification of an ER retrieval signal in a retroviral glycoprotein. Cell 1995;82: 543-4.
47. Gelderblom H, Frank H. Spumavirinae. In: Nermut MV, Steven AC, eds. Animal virus structure. Amsterdam: Elsevier, 1987:305-11.
48. Konvalinka J, Löchelt M, Zentgraf H, Flügel RM, Kräusslich H-G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a pol polyprotein. J Virol 1995;69:7264-8.
49. Schmidt M, Rethwilm A. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 1995;210:167-78.
50. Russel DW, Miller AD. Foamy virus vectors. J Virol 1996; 70:217-22.
51. Bieniasz PD, Rethwilm A, McClure MO. Gene transfer using replication defective human foamy virus vectors (submitted for publication).
52. Miller RH, Robinson WS. Common evolutionary origin of hepatitis B virus and retrovirus. Proc Natl Acad Sci USA 1986;83:2531-5.